Diagnostic imaging market to reach USD 41 billion by 2030

The “Diagnostic imaging: Global strategic business report” report has been added to ResearchAndMarkets.com’s offering.

The global market for diagnostic imaging estimated at US$27.6 Billion in the year 2022, is projected to reach a revised size of US$41 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2022-2030.

X-ray imaging, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the MRI segment is readjusted to a revised 5.4% CAGR for the next 8-year period.

The U.S. market is estimated at $8.5 Billion, while China is forecast to grow at 7.2% CAGR

The diagnostic imaging market in the U.S. is estimated at US$8.5 Billion in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 4.5% respectively over the 2022-2030 period.

Within Europe, Germany is forecast to grow at approximately 4.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.9 Billion by the year 2030.

Select competitors (Total 66 featured) –

• Carestream Health, Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• GE Healthcare
• Hitachi Ltd.
• Koninklijke Philips NV
• Samsung Medison Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers
• Toshiba Medical Systems Corporation

Research and Markets